Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference
TEL AVIV, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the Leerink Partners Global Healthcare Conference 2026, details as below.
A live webcast of the discussion, including presentation slides, will be available at the link below. A replay will remain accessible for 365 days following the event.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Who Is John Waldron? Goldman's Likely Next CEO and His 2021 Bitcoin Remarks
MEDPACE HOLDINGS, INC. <MEDP.O>: BAIRD RAISES TARGET PRICE TO $638 FROM $624
Goldman Sachs Explains Why Not to Buy the 5%+ Bonds and Rather Stick to AI
Midterm Year Q4 Averages 5.5% Gains: Stovall Explains Where the Gains Usually Come From
